Rarity Bioscience AB

Our superRCA technology delivers unmatched sensitivity for detecting low-frequency mutations — enabling deeper insights into disease biology and earlier detection of relapse. A growing portfolio of superRCA kits is already in the hands of researchers and clinicians, with more on the way. We are about 30 people in Uppsala, working across functions without unnecessary layers.